Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Completes $1B Senior Notes Placement

NEW YORK (GenomeWeb) – Hologic said Friday that it has completed a previously announced private placement of $1 billion in senior notes.

In a filing with the US Securities and Exchange Commission, the firm said it allocated $600 million of its 4.375 percent senior notes due in 2025 at an offer price of 100 percent of the aggregate principal amount of its 2025 notes, plus accrued and unpaid interest from Oct. 10, 2017. It allocated $400 million of its new 4.625 percent senior notes due in 2028 at an offer price of 100 percent of the aggregate principal amount of the 2028 notes. 

The firm has said that it intends to use the net proceeds and available cash, which could include funds from a secured revolving credit facility, to redeem its outstanding 5.25 percent senior notes due in 2022 in the amount of $1 billion.

The Scan

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.

Topical Compound to Block EGFR Inhibitors May Ease Skin Toxicities, Study Finds

A topical treatment described in Science Translational Medicine may limit skin toxicities seen with EGFR inhibitor therapy.

Dozen Genetic Loci Linked to Preeclampsia Risk in New GWAS

An analysis of genome-wide association study data in JAMA Cardiology finds genetic loci linked to preeclampsia that have ties to blood pressure.

Cancer Survival Linked to Mutational Burden in Pan-Cancer Analysis

A pan-cancer paper appearing in JCO Precision Oncology suggests tumor mutation patterns provide clues for predicting cancer survival that are independent of other prognostic factors.